With many organisations beginning to invest in behavioural science, we’ve been writing about the benefits for pharma companies. From optimising early drug design and development to addressing complex barriers to adoption in prescribing new drugs, we’ve been shouting about how you can improve the impact of your communications and achieve real change. Read on for our insights.